Imperva (NASDAQ: IMPV) reported Q2 EPS of $0.24, $0.19 better than the analyst estimate of $0.05. Revenue for the quarter came in at $74.4 million versus the consensus estimate of $74.33 million.

GUIDANCE:

Imperva sees Q3 2017 EPS of $0.22-$0.26, versus the consensus of $0.10. Imperva sees Q3 2017 revenue of $81-83 million, versus the consensus of $82.4 million.

Imperva sees FY 2017 EPS of $0.78-$0.82, versus the consensus of $0.45. Imperva sees FY 2017 revenue of $319.8-322.8 million, versus the consensus of $321.3 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.